(HealthDay News) — Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared with sulfonylureas among adults with type 2 diabetes ...

(HealthDay News) — Among survivors of drug overdose, fewer than half visited the emergency department, according to a study published online in JAMA Network Open.

Cardiovascular, kidney, and metabolic (CKM) syndrome affects nearly 90% of adults in the US, but most people don't know it. (HealthDay News) — Most U.S. adults have not heard of ...

Cancer deaths have increased by more than 70% globally over the last 3 decades and are estimated to continue to climb, researchers report.

Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

Unlike traditional Medicare patients, Medicare Advantage enrollees who need major genitourinary or gastrointestinal cancer surgery frequently use lower quality hospitals rather than high-quality ...

A substudy of the phase 1/2 KEYMAKER-U03 trial tested novel pembrolizumab-based triplet regimens for first-line treatment of advanced clear cell renal cell carcinoma (ccRCC).

In MIBC patients, ctDNA-guided, adjuvant atezolizumab treatment is associated with significant survival improvements over placebo.

In the absence of head-to-head randomized trials, investigators performed a network meta-analysis to compared drugs for post-transplant diabetes.

Higher prevalence was seen for antiviral-treated patients compared with untreated counterparts. (HealthDay News) — Patients with chronic hepatitis B (CHB) have an increased prevalence of chronic ...

Micro-energy treatments include low-intensity extracorporeal shockwave therapy, low-intensity pulsed ultrasound, and electromagnetic fields.